長期投資家のためのIR情報
バリュートレンド

【4551】鳥居薬品
医薬品。親会社はJT。
類似企業:
【業界1位】 小野薬品工業
【売上同水準】 扶桑薬品工業 JCRファーマ

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2024.12 2024/10/31 Q3予 61,200 +0.8% +4.4% 6,700 +6.3% +15.5% 6,800 +6.3% +17.2% 5,100 +6.3% +8.5%
2024.12 2024/07/31 Q2予 60,700 +3.6% +3.6% 6,300 +8.6% +8.6% 6,400 +10.3% +10.3% 4,800 +2.1% +2.1%
2024.12 2024/04/26 Q1予 58,600 0.0% 0.0% 5,800 0.0% 0.0% 5,800 0.0% 0.0% 4,700 0.0% 0.0%
2024.12 2024/02/09 当初予 58,600 - - - 5,800 - - - 5,800 - - - 4,700 - - -
2023.12 2024/02/09 54,638 +1.2% +7.3% 5,035 +11.9% +22.8% 5,307 +12.9% +20.6% 4,119 +21.1% +32.9%
2023.12 2023/10/31 Q3予 54,000 +2.5% +6.1% 4,500 +9.8% +9.8% 4,700 +6.8% +6.8% 3,400 +9.7% +9.7%
2023.12 2023/07/31 Q2予 52,700 +3.5% +3.5% 4,100 0.0% 0.0% 4,400 +7.3% 0.0% 3,100 0.0% 0.0%
2023.12 2023/04/28 Q1予 50,900 0.0% 0.0% 4,100 0.0% 0.0% 4,100 -6.8% -6.8% 3,100 0.0% 0.0%
2023.12 2023/02/10 当初予 50,900 - - - 4,100 - - - 4,400 - - - 3,100 - - -
2022.12 2023/02/10 48,896 -0.6% +1.4% 5,540 -7.7% +6.5% 5,537 -7.7% +2.5% 3,944 -8.3% +3.8%
2022.12 2022/10/31 Q3予 49,200 -1.2% +2.1% 6,000 -3.2% +15.4% 6,000 -1.6% +11.1% 4,300 -2.3% +13.2%
2022.12 2022/07/29 Q2予 49,800 +3.3% +3.3% 6,200 +19.2% +19.2% 6,100 +17.3% +13.0% 4,400 +15.8% +15.8%
2022.12 2022/04/28 Q1予 48,200 0.0% 0.0% 5,200 0.0% 0.0% 5,200 -3.7% -3.7% 3,800 0.0% 0.0%
2022.12 2022/02/10 当初予 48,200 - - - 5,200 - - - 5,400 - - - 3,800 - - -
2021.12 2022/02/10 46,987 +0.2% +2.8% 4,656 +3.5% +22.5% 4,847 +3.1% +18.2% 3,374 +5.4% +25.0%
2021.12 2021/10/29 Q3予 46,900 +1.1% +2.6% 4,500 +12.5% +18.4% 4,700 +11.9% +14.6% 3,200 +14.3% +18.5%
2021.12 2021/07/30 Q2予 46,400 +1.5% +1.5% 4,000 +5.3% +5.3% 4,200 +2.4% +2.4% 2,800 +3.7% +3.7%
2021.12 2021/04/28 Q1予 45,700 0.0% 0.0% 3,800 0.0% 0.0% 4,100 0.0% 0.0% 2,700 0.0% 0.0%
2021.12 2021/02/04 当初予 45,700 - - - 3,800 - - - 4,100 - - - 2,700 - - -
2020.12 2021/02/04 41,700 +1.7% +0.2% 4,738 +12.8% +57.9% 4,971 +10.5% +50.6% 3,495 +12.7% +66.4%
2020.12 2020/10/30 Q3予 41,000 +0.2% -1.4% 4,200 +13.5% +40.0% 4,500 +12.5% +36.4% 3,100 +19.2% +47.6%
2020.12 2020/07/31 Q2予 40,900 -1.7% -1.7% 3,700 +23.3% +23.3% 4,000 +21.2% +21.2% 2,600 +23.8% +23.8%
2020.12 2020/04/30 Q1予 41,600 0.0% 0.0% 3,000 0.0% 0.0% 3,300 0.0% 0.0% 2,100 0.0% 0.0%
2020.12 2020/02/06 当初予 41,600 - - - 3,000 - - - 3,300 - - - 2,100 - - -
2019.12 2020/02/06 42,998 +0.0% +13.2% 1,430 0.0% +144.7% 1,691 +0.1% +154.5% 27,367 +0.0% +21.6%
2019.12 2020/01/20 修正予 42,990 +0.7% +13.1% 1,430 +104.3% +144.7% 1,690 +69.0% +154.5% 27,360 +6.5% +21.6%
2019.12 2019/10/31 Q3予 42,700 +4.7% +12.4% 700 +200.0% +121.9% 1,000 +350.0% +132.3% 25,700 +4.0% +14.2%
2019.12 2019/07/31 Q2予 40,800 +7.4% +7.4% -700 +78.1% +78.1% -400 +87.1% +87.1% 24,700 +9.8% +9.8%
2019.12 2019/04/25 Q1予 38,000 0.0% 0.0% -3,200 0.0% 0.0% -3,100 0.0% 0.0% 22,500 0.0% 0.0%
2019.12 2019/02/06 当初予 38,000 - - - -3,200 - - - -3,100 - - - 22,500 - - -
2018.12 2019/02/06 62,551 +0.9% +3.0% 4,951 +20.8% +41.5% 5,080 +21.0% +41.1% 1,164 -61.2% -55.2%
2018.12 2018/10/31 Q3予 62,000 +0.8% +2.1% 4,100 +17.1% +17.1% 4,200 +16.7% +16.7% 3,000 +15.4% +15.4%
2018.12 2018/07/30 Q2予 61,500 +1.3% +1.3% 3,500 0.0% 0.0% 3,600 0.0% 0.0% 2,600 0.0% 0.0%
2018.12 2018/04/26 Q1予 60,700 0.0% 0.0% - - - - 3,600 0.0% 0.0% 2,600 0.0% 0.0%
2018.12 2018/02/06 当初予 60,700 - - - 3,500 - - - 3,600 - - - 2,600 - - -
2017.12 2018/02/06 64,135 +0.0% -0.6% 6,281 +0.0% +18.5% 6,403 +0.0% +18.6% 4,718 +0.2% +21.0%
2017.12 2018/01/22 修正予 64,130 +1.6% -0.6% 6,280 +25.6% +18.5% 6,400 +25.5% +18.5% 4,710 +23.9% +20.8%
2017.12 2017/10/26 Q3予 63,100 0.0% -2.2% 5,000 -5.7% -5.7% 5,100 -5.6% -5.6% 3,800 -2.6% -2.6%
2017.12 2017/07/27 Q2予 63,100 -2.2% -2.2% 5,300 0.0% 0.0% 5,400 0.0% 0.0% 3,900 0.0% 0.0%
2017.12 2017/04/27 Q1予 64,500 0.0% 0.0% 5,300 0.0% 0.0% 5,400 0.0% 0.0% 3,900 0.0% 0.0%
2017.12 2017/02/02 当初予 64,500 - - - 5,300 - - - 5,400 - - - 3,900 - - -
2016.12 2017/02/02 60,206 +0.0% -1.3% 3,819 +0.2% +15.7% 3,999 +0.2% +17.6% 2,839 +2.5% +23.4%
2016.12 2017/01/23 修正予 60,200 -0.5% -1.3% 3,810 +27.0% +15.5% 3,990 +28.7% +17.4% 2,770 +31.9% +20.4%
2016.12 2016/10/28 Q3予 60,500 -0.8% -0.8% 3,000 0.0% -9.1% 3,100 0.0% -8.8% 2,100 +5.0% -8.7%
2016.12 2016/07/28 Q2予 61,000 0.0% 0.0% 3,000 -9.1% -9.1% 3,100 -8.8% -8.8% 2,000 -13.0% -13.0%
2016.12 2016/04/27 Q1予 61,000 0.0% 0.0% 3,300 0.0% 0.0% 3,400 0.0% 0.0% 2,300 0.0% 0.0%
2016.12 2016/02/03 当初予 61,000 - - - 3,300 - - - 3,400 - - - 2,300 - - -
2015.12 2016/02/03 62,378 +0.0% -1.0% 4,919 +0.2% -10.6% 5,135 +0.1% -8.3% 3,527 +0.2% +0.8%
2015.12 2016/01/18 修正予 62,370 +1.7% -1.0% 4,910 +22.8% -10.7% 5,130 +22.1% -8.4% 3,520 +35.4% +0.6%
2015.12 2015/10/30 Q3予 61,300 -1.4% -2.7% 4,000 -7.0% -27.3% 4,200 -4.5% -25.0% 2,600 -7.1% -25.7%
2015.12 2015/07/29 Q2予 62,200 -1.3% -1.3% 4,300 -21.8% -21.8% 4,400 -21.4% -21.4% 2,800 -20.0% -20.0%
2015.12 2015/04/28 Q1予 63,000 0.0% 0.0% 5,500 0.0% 0.0% 5,600 0.0% 0.0% 3,500 0.0% 0.0%
2015.12 2015/02/04 当初予 63,000 - - - 5,500 - - - 5,600 - - - 3,500 - - -
2014.12 2015/02/04 43,504 +0.0% +1.4% 4,032 +15.2% +49.3% 4,142 +15.1% +47.9% 2,419 +21.0% +51.2%
2014.12 2014/10/30 Q2予 43,500 +1.4% +1.4% 3,500 +29.6% +29.6% 3,600 +28.6% +28.6% 2,000 +25.0% +25.0%
2014.12 2014/07/30 Q1予 42,900 0.0% 0.0% 2,700 0.0% 0.0% 2,800 0.0% 0.0% 1,600 0.0% 0.0%
2014.12 2014/04/24 当初予 42,900 - - - 2,700 - - - 2,800 - - - 1,600 - - -
2014.03 2014/04/24 58,109 +0.0% +0.0% 4,987 +0.1% +0.1% 5,124 +0.1% +0.1% 3,352 +0.1% +0.1%
2014.03 2014/04/14 当初予 58,100 - - - 4,980 - - - 5,120 - - - 3,350 - - -
ページトップへ戻る